Company profile
Aminex Therapeutics company profile
Aminex Therapeutics, Inc. is a drug development company focused on the discovery, development, and commercialization of suppressor cell modulators (SCM), a new class of small molecule cancer immunotherapies that enable the immune system to attack cancer by regulating myeloid-derived suppressor cells. Aminex has extensively demonstrated, in animal trials, the potential of its lead drug, AMX-513, to be effective alone and to improve overall therapy when used in combination with other cancer treatments. Aminex's vision is to make significant treatment contributions for a wide range of cancers and to ease the rising costs of cancer therapy.
Business identity
- Website
- http://www.aminextx.com
- Contact email
- [email protected]
- Phone number
- (425) 286-4222
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2009-01-01
Headquarters
- Headquarters
- Evans, Colorado, United States
- Postal code
- 98034
- Country code
- US
- Continent
- North America